Stockscreener 앱 받기
1.875
0.79%
-0.015
시간 외 거래:
1.80
-0.075
-4.00%
전일 마감가:
$1.89
열려 있는:
$1.87
하루 거래량:
10,154
Relative Volume:
0.02
시가총액:
$2.78M
수익:
$502.40K
순이익/손실:
$-7.91M
주가수익비율:
-0.188
EPS:
-9.972
순현금흐름:
$-4.32M
1주 성능:
-0.27%
1개월 성능:
+3.59%
6개월 성능:
-67.39%
1년 성능:
-88.90%
1일 변동 폭
$1.81
$1.91
1주일 범위
$1.716
$1.915
52주 변동 폭
$1.41
$35.99
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
명칭
60 Degrees Pharmaceuticals Inc
전화
202-327-5422
주소
1025 CONNECTICUT AVENUE NW, WASHINGTON
SXTP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.875 | 2.78M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc 주식(SXTP)의 최신 뉴스
HC Wainwright Reiterates “Neutral” Rating for 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World
60 Degrees Pharmaceuticals Announces 2024 Annual Results - The Manila Times
140% Revenue Surge: 60 Degrees Pharma Expands Drug Access After FDA Approval - Stock Titan
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Sees Large Growth in Short Interest - Defense World
Short Interest in Hilton Small-MidCap Opportunity ETF (NASDAQ:SMCO) Declines By 93.8% - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given Sell (E+) Rating at Weiss Ratings - Defense World
CNS Pharma Stock Price, Quotes and Forecasts | NASDAQ:CNSP - Benzinga
IntegriChain Hosts Revenue Analytics Collaborative Summit - PR Newswire
Research Analysts Issue Forecasts for SXTP Q4 Earnings - Defense World
HC Wainwright Reaffirms “Neutral” Rating for 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World
What is HC Wainwright’s Estimate for SXTP Q1 Earnings? - Defense World
60 Degrees Pharmaceuticals announces 1-for-5 reverse stock split; shares fall - MSN
A company insider recently bought 6,000 shares of 60 Degrees Pharmaceuticals Inc [SXTP]. Should You Buy? - Knox Daily
60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split - GlobeNewswire
From Malaria to New Markets: How This Pharma CEO Plans to Transform ARAKODA's Future - Stock Titan
60 Degrees Pharmaceuticals enacts reverse stock split By Investing.com - Investing.com Nigeria
60 Degrees Pharmaceuticals enacts reverse stock split - Investing.com India
60 Degrees Pharmaceuticals to Implement 1-for-5 Reverse Stock Split; Shares Down - Marketscreener.com
60 Degrees Pharmaceuticals, Inc. Announces 1-for-5 Reverse Stock Split to Comply with Nasdaq Listing Requirements - Nasdaq
Can This 1-for-5 Reverse Split Save 60 Degrees Pharma's Nasdaq Status? - StockTitan
Weiss Ratings Reaffirms “Sell (E+)” Rating for 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World
60 Degrees Pharmaceuticals files to sell 3.74M shares of common stock for holders - MSN
Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF® - The Manila Times
60 Degrees Gets FDA Clearance to Import Antimalarial From Australia to Ensure Supply Continuity - Marketscreener.com
Sixty Degrees Pharmaceuticals to Ensure Continuity of - GlobeNewswire
Malaria Drug Shortage Averted: FDA Green-Lights Australian Import for Critical U.S. Supply - StockTitan
60 Degrees Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
Bioceres Crop Solutions Corp (BIOX) Becoming More Attractive for Investors - Knox Daily
Balance Sheet Insights: 60 Degrees Pharmaceuticals Inc (SXTP)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Insiders Give Up US$71k As 60 Degrees Pharmaceuticals Stock Drops To US$0.55 - Simply Wall St
60 Degrees Pharmaceuticals Inc [SXTP] Records 200-Day SMA of $1.8142 - Knox Daily
60 Degrees Pharmaceuticals, Inc. Closes Registered Direct Offering and Concurrent Private Placement Raising Approximately $1.075 Million - Nasdaq
Pharmaceutical Funding Alert: 60 Degrees Secures Fresh Capital Through Strategic Share Offering - StockTitan
Form 424B5 60 DEGREES PHARMACEUTICA - StreetInsider.com
How does 60 Degrees Pharmaceuticals Inc (SXTP) change from a tortoise to a hare? - SETE News
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering - citybiz
60 Degrees Pharmaceuticals Secures $1.1 Mln In Registered Direct Offering - Nasdaq
60 Degrees Pharmaceuticals, Inc. Announces $1.075 Million Registered Direct Offering and Concurrent Private Placement of Common Stock and Warrants - Nasdaq
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
Pharma Stock Alert: SXTP Secures Fresh Capital Through Strategic Share Offering at $0.715 - StockTitan
Weiss Ratings Reiterates Sell (E+) Rating for 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World
RedChip Launches RedChat: Revolutionary AI Chatbot for Small-Cap Stock Analysis - ACCESS Newswire
SXTP stock touches 52-week low at $0.7 amid market challenges - MSN
60 Degrees Pharmaceuticals, Inc. Closes Registered Direct Offering and Concurrent Private Placement Raising Approximately $1.043 Million - Nasdaq
60 Degrees Pharma Announces Closing of $1.043 Million - GlobeNewswire
60 Degrees Pharma Secures Fresh Capital: Inside the $1M Financing Deal That's Turning Heads - StockTitan
60 Degrees Pharmaceuticals announces stock and warrant sale - MSN
US Stocks Mixed; General Dynamics Earnings Top Views - Benzinga
60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times
60 Degrees Pharmaceuticals Inc (SXTP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.00%
자본화:
|
볼륨(24시간):